Metraipolis › archive › dc_967dd90be031

Integrated genetic screening identifies FEN1 as a selective vulnerability and temozolomide resistance mediator in glioblastoma stem cells — Europe PMC PMID:42770249

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42770249
DOI
10.1158/2767-9764.crc-26-0150
License (as archived)
solo-consultazione
Archived
2026-10-08T00:31:23.444Z
SHA-256 of the archived text
f693ed11c8ae83d19e9d6567fb59d2a59aab40fcad5fc6bfa6e00a56d2d8bd12
Stable URL of this page
https://metraipolis.com/documento/dc_967dd90be031

How to cite

Integrated genetic screening identifies FEN1 as a selective vulnerability and temozolomide resistance mediator in glioblastoma stem cells — Europe PMC PMID:42770249 — Europe PMC (en), https://europepmc.org/article/MED/42770249 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_967dd90be031 (Metraipolis archive dc_967dd90be031, sha256 f693ed11c8ae83d19e9d6567fb59d2a59aab40fcad5fc6bfa6e00a56d2d8bd12)
BibTeX
@misc{dc967dd90be031,
  title = {Integrated genetic screening identifies FEN1 as a selective vulnerability and temozolomide resistance mediator in glioblastoma stem cells — Europe PMC PMID:42770249},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42770249},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_967dd90be031; sha256 f693ed11c8ae83d19e9d6567fb59d2a59aab40fcad5fc6bfa6e00a56d2d8bd12},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42770249. Agents can read the archived copy with the MCP tool read_document.